These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

295 related items for PubMed ID: 31679275

  • 1. Evaluation of LncRNA ANRIL Potential in Hepatic Cancer Progression.
    Ji Y, Sun H, Liang H, Wang Y, Lu M, Guo Z, Lv Z, Ren W.
    J Environ Pathol Toxicol Oncol; 2019; 38(2):119-131. PubMed ID: 31679275
    [Abstract] [Full Text] [Related]

  • 2. Knockdown of LncRNA ANRIL suppresses cell proliferation, metastasis, and invasion via regulating miR-122-5p expression in hepatocellular carcinoma.
    Ma J, Li T, Han X, Yuan H.
    J Cancer Res Clin Oncol; 2018 Feb; 144(2):205-214. PubMed ID: 29127494
    [Abstract] [Full Text] [Related]

  • 3. The long noncoding RNA NEAT1 contributes to hepatocellular carcinoma development by sponging miR-485 and enhancing the expression of the STAT3.
    Zhang XN, Zhou J, Lu XJ.
    J Cell Physiol; 2018 Sep; 233(9):6733-6741. PubMed ID: 29219178
    [Abstract] [Full Text] [Related]

  • 4. Knockdown long non-coding RNA ANRIL inhibits proliferation, migration and invasion of HepG2 cells by down-regulation of miR-191.
    Huang D, Bi C, Zhao Q, Ding X, Bian C, Wang H, Wang T, Liu H.
    BMC Cancer; 2018 Sep 24; 18(1):919. PubMed ID: 30249208
    [Abstract] [Full Text] [Related]

  • 5. LncRNA DGCR5 represses the development of hepatocellular carcinoma by targeting the miR-346/KLF14 axis.
    Wang YG, Liu J, Shi M, Chen FX.
    J Cell Physiol; 2018 Jan 24; 234(1):572-580. PubMed ID: 30216442
    [Abstract] [Full Text] [Related]

  • 6. LINC01433 promotes hepatocellular carcinoma progression via modulating the miR-1301/STAT3 axis.
    Huang H, Bu YZ, Zhang XY, Liu J, Zhu LY, Fang Y.
    J Cell Physiol; 2019 May 24; 234(5):6116-6124. PubMed ID: 30317567
    [Abstract] [Full Text] [Related]

  • 7. LncRNA TUG1 interacting with miR-144 contributes to proliferation, migration and tumorigenesis through activating the JAK2/STAT3 pathway in hepatocellular carcinoma.
    Lv J, Kong Y, Gao Z, Liu Y, Zhu P, Yu Z.
    Int J Biochem Cell Biol; 2018 Aug 24; 101():19-28. PubMed ID: 29791864
    [Abstract] [Full Text] [Related]

  • 8. Long non-coding RNA PTTG3P functions as an oncogene by sponging miR-383 and up-regulating CCND1 and PARP2 in hepatocellular carcinoma.
    Zhou Q, Zhang W, Wang Z, Liu S.
    BMC Cancer; 2019 Jul 24; 19(1):731. PubMed ID: 31340767
    [Abstract] [Full Text] [Related]

  • 9. Long non-coding RNA CASC2 suppresses epithelial-mesenchymal transition of hepatocellular carcinoma cells through CASC2/miR-367/FBXW7 axis.
    Wang Y, Liu Z, Yao B, Li Q, Wang L, Wang C, Dou C, Xu M, Liu Q, Tu K.
    Mol Cancer; 2017 Jul 17; 16(1):123. PubMed ID: 28716020
    [Abstract] [Full Text] [Related]

  • 10. Long non-coding RNA TPTEP1 inhibits hepatocellular carcinoma progression by suppressing STAT3 phosphorylation.
    Ding H, Liu J, Zou R, Cheng P, Su Y.
    J Exp Clin Cancer Res; 2019 May 09; 38(1):189. PubMed ID: 31072375
    [Abstract] [Full Text] [Related]

  • 11. A novel lncRNA MCM3AP-AS1 promotes the growth of hepatocellular carcinoma by targeting miR-194-5p/FOXA1 axis.
    Wang Y, Yang L, Chen T, Liu X, Guo Y, Zhu Q, Tong X, Yang W, Xu Q, Huang D, Tu K.
    Mol Cancer; 2019 Feb 19; 18(1):28. PubMed ID: 30782188
    [Abstract] [Full Text] [Related]

  • 12. LncRNA DBH-AS1 facilitates the tumorigenesis of hepatocellular carcinoma by targeting miR-138 via FAK/Src/ERK pathway.
    Bao J, Chen X, Hou Y, Kang G, Li Q, Xu Y.
    Biomed Pharmacother; 2018 Nov 19; 107():824-833. PubMed ID: 30142544
    [Abstract] [Full Text] [Related]

  • 13. LncRNA SNHG7 accelerates the proliferation, migration and invasion of hepatocellular carcinoma cells via regulating miR-122-5p and RPL4.
    Yang X, Sun L, Wang L, Yao B, Mo H, Yang W.
    Biomed Pharmacother; 2019 Oct 19; 118():109386. PubMed ID: 31545291
    [Abstract] [Full Text] [Related]

  • 14. LncRNA CRNDE promotes hepatocellular carcinoma cell proliferation, invasion, and migration through regulating miR-203/ BCAT1 axis.
    Ji D, Jiang C, Zhang L, Liang N, Jiang T, Yang B, Liang H.
    J Cell Physiol; 2019 May 19; 234(5):6548-6560. PubMed ID: 30230527
    [Abstract] [Full Text] [Related]

  • 15. LINC00339 regulates ROCK1 by miR-152 to promote cell proliferation and migration in hepatocellular carcinoma.
    Chen K, Zhang L.
    J Cell Biochem; 2019 Sep 19; 120(9):14431-14443. PubMed ID: 31081143
    [Abstract] [Full Text] [Related]

  • 16. Long non-coding RNA TINCR promotes hepatocellular carcinoma proliferation and invasion via STAT3 signaling by direct interacting with T-cell protein tyrosine phosphatase (TCPTP).
    Tang C, Feng W, Bao Y, Du H.
    Bioengineered; 2021 Dec 19; 12(1):2119-2131. PubMed ID: 34057016
    [Abstract] [Full Text] [Related]

  • 17. Silencing of long noncoding RNA LEF1-AS1 prevents the progression of hepatocellular carcinoma via the crosstalk with microRNA-136-5p/WNK1.
    Dong H, Jian P, Yu M, Wang L.
    J Cell Physiol; 2020 Oct 19; 235(10):6548-6562. PubMed ID: 32068261
    [Abstract] [Full Text] [Related]

  • 18. LINC00174 is an oncogenic lncRNA of hepatocellular carcinoma and regulates miR-320/S100A10 axis.
    Zhao JT, Chi BJ, Sun Y, Chi NN, Zhang XM, Sun JB, Chen Y, Xia Y.
    Cell Biochem Funct; 2020 Oct 19; 38(7):859-869. PubMed ID: 32128852
    [Abstract] [Full Text] [Related]

  • 19. In vivo and in vitro effects of microRNA-221 on hepatocellular carcinoma development and progression through the JAK-STAT3 signaling pathway by targeting SOCS3.
    Huang S, Zhou D, Li YX, Ming ZY, Li KZ, Wu GB, Chen C, Zhao YN.
    J Cell Physiol; 2019 Apr 19; 234(4):3500-3514. PubMed ID: 30370582
    [Abstract] [Full Text] [Related]

  • 20. MiR-137 suppresses migration and invasion by targeting EZH2-STAT3 signaling in human hepatocellular carcinoma.
    Huang B, Huang M, Li Q.
    Pathol Res Pract; 2018 Dec 19; 214(12):1980-1986. PubMed ID: 30274685
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.